Page last updated: 2024-11-02

pirenzepine and Angor Pectoris

pirenzepine has been researched along with Angor Pectoris in 2 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lyzohub, VH1
Pliskevyvch, DA1
Nikoliuk, LS1
Savchenko, OV1
Marraccini, P1
Orsini, E1
Nassi, G1
Michelassi, C1
L'Abbate, A1

Trials

1 trial available for pirenzepine and Angor Pectoris

ArticleYear
Usefulness of pirenzepine, an M1 antimuscarinic agent, for effort myocardial ischemia.
    The American journal of cardiology, 1992, Jun-01, Volume: 69, Issue:17

    Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Isosorbide

1992

Other Studies

1 other study available for pirenzepine and Angor Pectoris

ArticleYear
[Gastrozepin therapy of gallbladder motility disorders in patients with ischemic heart disease].
    Likars'ka sprava, 2002, Issue:1

    Topics: Adult; Angina Pectoris; Anti-Ulcer Agents; Gallbladder Diseases; Gallbladder Emptying; Humans; Incid

2002